ArticleFrontiers in public health2024
Policy instruments for the governance of the social drivers of health data in clinical and research settings: a policy mapping brief.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This paper maps policy instrument use for the social drivers of health (SDoH) data governance in clinical and research settings. In the United States, Centers for Medicare and Medicaid Services (CMS) and National Institutes of Health (NIH) advocate for standardized data capture. Yet, challenges persist, including limited adoption of CMS-issued SDoH risk codes and gaps in reporting SDoH in clinical trial literature. The mapping across clinical and research SDoH reporting emerges as a comprehensive solution that requires policy support. Specifically, the findings presented in this paper support future policy development through regulatory instruments, fiscal incentives, and knowledge exchange. Actionable recommendations for the United States and international contexts include convening interdisciplinary taskforces, developing agency guidelines for process evaluation, and establishing ethical principles for SDoH data use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.